125 related articles for article (PubMed ID: 23819792)
1. Mammalian target of rapamycin (mTOR) inhibition does not prevent lung adenocarcinoma-induced malignant pleural effusion.
Vazakidou ME; Magkouta S; Moschos C; Kalomenidis I
Respirology; 2014 Feb; 19(2):290-292. PubMed ID: 23819792
[TBL] [Abstract][Full Text] [Related]
2. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion.
Psallidas I; Stathopoulos GT; Maniatis NA; Magkouta S; Moschos C; Karabela SP; Kollintza A; Simoes DC; Kardara M; Vassiliou S; Papiris SA; Roussos C; Kalomenidis I
Oncogene; 2013 Jan; 32(4):528-35. PubMed ID: 22370646
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-alpha promotes malignant pleural effusion.
Stathopoulos GT; Kollintza A; Moschos C; Psallidas I; Sherrill TP; Pitsinos EN; Vassiliou S; Karatza M; Papiris SA; Graf D; Orphanidou D; Light RW; Roussos C; Blackwell TS; Kalomenidis I
Cancer Res; 2007 Oct; 67(20):9825-34. PubMed ID: 17942913
[TBL] [Abstract][Full Text] [Related]
4. Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivo.
Vazakidou ME; Magkouta S; Moschos C; Psallidas I; Pappas A; Psarra K; Kalomenidis I
Respirology; 2015 Nov; 20(8):1263-71. PubMed ID: 26245309
[TBL] [Abstract][Full Text] [Related]
5. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
6. Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion.
Magkouta S; Pappas A; Moschos C; Vazakidou ME; Psarra K; Kalomenidis I
Oncotarget; 2016 Apr; 7(15):20249-59. PubMed ID: 26959120
[TBL] [Abstract][Full Text] [Related]
7. Mast cells mediate malignant pleural effusion formation.
Giannou AD; Marazioti A; Spella M; Kanellakis NI; Apostolopoulou H; Psallidas I; Prijovich ZM; Vreka M; Zazara DE; Lilis I; Papaleonidopoulos V; Kairi CA; Patmanidi AL; Giopanou I; Spiropoulou N; Harokopos V; Aidinis V; Spyratos D; Teliousi S; Papadaki H; Taraviras S; Snyder LA; Eickelberg O; Kardamakis D; Iwakura Y; Feyerabend TB; Rodewald HR; Kalomenidis I; Blackwell TS; Agalioti T; Stathopoulos GT
J Clin Invest; 2015 Jun; 125(6):2317-34. PubMed ID: 25915587
[TBL] [Abstract][Full Text] [Related]
8. Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion.
Marazioti A; Kairi CA; Spella M; Giannou AD; Magkouta S; Giopanou I; Papaleonidopoulos V; Kalomenidis I; Snyder LA; Kardamakis D; Stathopoulos GT
PLoS One; 2013; 8(8):e71207. PubMed ID: 23967166
[TBL] [Abstract][Full Text] [Related]
9. EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenocarcinoma with Tarceva therapy.
Guo H; Wan Y; Tian G; Liu Q; Kang Y; Li Y; Yao Z; Lin D
Oncol Rep; 2012 Mar; 27(3):880-90. PubMed ID: 22134479
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer.
Cui R; Takahashi F; Ohashi R; Yoshioka M; Gu T; Tajima K; Unnoura T; Iwakami S; Hirama M; Ishiwata T; Iwase A; Takahashi K
Lung Cancer; 2009 Mar; 63(3):368-74. PubMed ID: 18752867
[TBL] [Abstract][Full Text] [Related]
11. A modified experimental model of malignant pleural disease induced by lung Lewis carcinoma (LLC) cells.
Acencio MM; Puka J; Marchi E; Antonangelo L; Terra RM; Vargas FS; Capelozzi VL; Teixeira LR
J Transl Med; 2015 Sep; 13():302. PubMed ID: 26373420
[TBL] [Abstract][Full Text] [Related]
12. Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study.
Psallidas I; Karabela SP; Moschos C; Sherrill TP; Kollintza A; Magkouta S; Theodoropoulou P; Roussos C; Blackwell TS; Kalomenidis I; Stathopoulos GT
Mol Cancer; 2010 Mar; 9():56. PubMed ID: 20219102
[TBL] [Abstract][Full Text] [Related]
13. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.
Yeh HH; Lai WW; Chen HH; Liu HS; Su WC
Oncogene; 2006 Jul; 25(31):4300-9. PubMed ID: 16518408
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutical effects of pleural injecting recombinant human endostain to
malignant pleural effusion nude mice model].
Zhou M; Li M; Yang H; Hu C
Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):266-71. PubMed ID: 25975296
[TBL] [Abstract][Full Text] [Related]
15. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma-induced malignant pleural effusion.
Tao H; Meng Q; Li M; Shi L; Tang J; Liu Z
Thorac Cancer; 2018 Feb; 9(2):298-304. PubMed ID: 29297985
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mTOR by temsirolimus contributes to prolonged survival of mice with pleural dissemination of non-small-cell lung cancer cells.
Ohara T; Takaoka M; Toyooka S; Tomono Y; Nishikawa T; Shirakawa Y; Yamatsuji T; Tanaka N; Fujiwara T; Naomoto Y
Cancer Sci; 2011 Jul; 102(7):1344-9. PubMed ID: 21521416
[TBL] [Abstract][Full Text] [Related]
19. Mutant KRAS promotes malignant pleural effusion formation.
Agalioti T; Giannou AD; Krontira AC; Kanellakis NI; Kati D; Vreka M; Pepe M; Spella M; Lilis I; Zazara DE; Nikolouli E; Spiropoulou N; Papadakis A; Papadia K; Voulgaridis A; Harokopos V; Stamou P; Meiners S; Eickelberg O; Snyder LA; Antimisiaris SG; Kardamakis D; Psallidas I; Marazioti A; Stathopoulos GT
Nat Commun; 2017 May; 8():15205. PubMed ID: 28508873
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Arsenic Trioxide in the Treatment of Malignant Pleural Effusion Caused by Pleural Metastasis of Lung Cancer.
Xie SL; Yang MH; Chen K; Huang H; Zhao XW; Zang YS; Li B
Cell Biochem Biophys; 2015 Apr; 71(3):1325-33. PubMed ID: 25413961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
